Tenaya Therapeutics, Inc.
TNYA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001858848
In the last 90 days, Tenaya Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 101 institutions reported holding it in 13F filings for Q2 2026, worth $39.7M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Tenaya Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +3 vs. Q4 2021
- Shares held
- 37.3M
- +1.99M (+5.6%) vs. Q4 2021
- Total value
- $439.9M
- −$227.7M (−34.1%) vs. Q4 2021
- New holders
- 7
- 22 more added
- Sold out
- 4
- 9 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $39.7M |
| Q1 2026 | 103 | $37.5M |
| Q4 2025 | 98 | $48.8M |
| Q3 2025 | 91 | $55.6M |
| Q2 2025 | 89 | $19.3M |
| Q1 2025 | 107 | $27.7M |
| Q4 2024 | 88 | $62.8M |
| Q3 2024 | 95 | $111.2M |
| Q2 2024 | 96 | $177.0M |
| Q1 2024 | 90 | $292.9M |
| Q4 2023 | 74 | $151.4M |
| Q3 2023 | 77 | $126.8M |
| Q2 2023 | 79 | $279.7M |
| Q1 2023 | 65 | $128.3M |
| Q4 2022 | 68 | $94.7M |
| Q3 2022 | 73 | $102.2M |
| Q2 2022 | 50 | $208.6M |
| Q1 2022 | 50 | $439.9M |
| Q4 2021 | 47 | $667.6M |
| Q3 2021 | 47 | $693.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Tenaya Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 120 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 367 | $4.00K | 0.00% | −2,923−88.8% | Reduced |
| Tower Research Capital LLC (TRC) | 988 | $12.0K | 0.00% | −1,156−53.9% | Reduced |
| Royal Bank of Canada | 1,758 | $21.0K | 0.00% | −1,145−39.4% | Reduced |
| Citigroup Inc | 2,003 | $24.0K | 0.00% | −2,818−58.5% | Reduced |
| Metropolitan Life Insurance Co | 2,194 | $25.8K | 0.00% | −2,237−50.5% | Reduced |
| Ameritas Investment Partners, Inc. | 2,217 | $26.0K | 0.00% | +1,149+107.6% | Added |
| Amalgamated Bank | 2,473 | $29.0K | 0.00% | +2,473 | New |
| Amalgamated Financial Corp. | 2,473 | $29.0K | 0.00% | +2,473 | New |
| Legal & General Group Plc | 2,737 | $32.0K | 0.00% | +1,432+109.7% | Added |
| STRS Ohio | 3,200 | $37.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 4,642 | $55.0K | 0.00% | +4,642 | New |
| Morgan Stanley | 11,537 | $135.0K | 0.00% | −18,661−61.8% | Reduced |
| California State Teachers Retirement System | 12,208 | $144.0K | 0.00% | +4,682+62.2% | Added |
| American International Group, Inc. | 14,195 | $167.0K | 0.00% | +6,794+91.8% | Added |
| Allspring Global Investments Holdings, LLC | 15,406 | $181.0K | 0.00% | −1,848−10.7% | Reduced |
| Deutsche Bank AG | 16,881 | $199.0K | 0.00% | +8,415+99.4% | Added |
| Wells Fargo & Company | 17,681 | $208.0K | 0.00% | −991−5.3% | Reduced |
| Bank of America Corp | 18,305 | $216.0K | 0.00% | +3,566+24.2% | Added |
| State of Wisconsin Investment Board | 18,600 | $219.0K | 0.00% | +18,600 | New |
| MetLife Investment Management | 18,722 | $220.5K | 0.00% | +12,865+219.7% | Added |
| JPMorgan Chase & Co | 21,876 | $258.0K | 0.00% | +9,647+78.9% | Added |
| New York State Common Retirement Fund | 22,585 | $266.0K | 0.00% | +10,547+87.6% | Added |
| Rhumbline Advisers | 22,798 | $269.0K | 0.00% | +12,646+124.6% | Added |
| Goldman Sachs Group Inc | 27,171 | $320.0K | 0.00% | +12,870+90.0% | Added |
| Woodline Partners LP | 37,568 | $443.0K | 0.01% | +37,568 | New |
| D. E. Shaw & Co., Inc. | 38,516 | $454.0K | 0.00% | +38,516 | New |
| Jasper Ridge Partners, L.P. | 44,395 | $523.0K | 0.03% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 51,739 | $564.0K | 0.00% | +21,031+68.5% | Added |
| Manufacturers Life Insurance Company, The | 52,219 | $608.7K | 0.00% | +52,219 | New |
| TD Asset Management Inc | 61,644 | $726.0K | 0.00% | +26,366+74.7% | Added |
| Charles Schwab Investment Management Inc | 68,704 | $810.0K | 0.00% | +33,161+93.3% | Added |
| Bank of New York Mellon Corp | 73,314 | $864.0K | 0.00% | +33,726+85.2% | Added |
| Northern Trust Corp | 231,459 | $2.73M | 0.00% | +91,586+65.5% | Added |
| State Street Corp | 295,389 | $3.48M | 0.00% | +80,318+37.3% | Added |
| Geode Capital Management, LLC | 368,217 | $4.34M | 0.00% | +139,078+60.7% | Added |
| StepStone Group LP | 462,163 | $5.44M | 0.41% | 00.0% | Unchanged |
| Commodore Capital LP | 513,930 | $6.05M | 1.35% | 00.0% | Unchanged |
| Deep Track Capital, LP | 546,923 | $6.44M | 0.42% | −215,394−28.3% | Reduced |
| Harvard Management Co Inc | 673,270 | $7.93M | 0.80% | 00.0% | Unchanged |
| Alphabet Inc. | 915,705 | $10.8M | 0.35% | 00.0% | Unchanged |
| Euclidean Capital LLC | 915,705 | $10.8M | 6.27% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,085,663 | $12.8M | 0.00% | +528,845+95.0% | Added |
| BlackRock Inc. | 2,428,872 | $28.6M | 0.00% | +555,928+29.7% | Added |
| RTW Investments, LP | 2,458,750 | $29.0M | 0.60% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,031,402 | $35.7M | 0.00% | +37,899+1.3% | Added |
| Ra Capital Management, L.P. | 3,551,508 | $41.8M | 0.91% | 00.0% | Unchanged |
| Casdin Capital, LLC | 3,586,818 | $42.3M | 1.89% | 00.0% | Unchanged |
| FMR LLC | 6,192,008 | $72.9M | 0.01% | +468,276+8.2% | Added |
| The Column Group LLC | 9,400,290 | $110.7M | 20.53% | 00.0% | Unchanged |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −26−100.0% | Sold out |